3,4-哒嗪二甲酸 | 129116-97-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 3,4-哒嗪二甲酸
• 英文名称: pyridazine-3,4-dicarboxylic acid
• CAS: 129116-97-8
• 化学式: C₆H₄N₂O₄
• mdl: MFCD18377803
• 分子量: 168.109
• InChiKey: RDQWJNPUOHXYCV-UHFFFAOYSA-N

物化性质

• 熔点：
  170 °C (decomp)
• 沸点：
  539.4±35.0 °C(Predicted)
• 密度：
  1.665±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  100
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3,4-哒嗪二甲酸 以 various solvent(s) 为溶剂， 以100%的产率得到4-哒嗪羧酸
  参考文献：
  名称：

  Vors, Jean-Pierre, Journal of Heterocyclic Chemistry, 1990, vol. 27, # 3, p. 579 - 582

  摘要：

  DOI：
• 作为产物：
  描述：

  6-ethoxy-3,4-diethoxycarbonyl-1-methoxycarbonyl-1,4,5,6-tetrahydropyridazine 在 sodium hydroxide 、 溴 、 溶剂黄146 作用下， 以 水 为溶剂， 反应 23.25h， 生成 3,4-哒嗪二甲酸
  参考文献：
  名称：

  Vors, Jean-Pierre, Journal of Heterocyclic Chemistry, 1990, vol. 27, # 3, p. 579 - 582

  摘要：

  DOI：

文献信息

• [EN] ALDOSE REDUCTASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE L'ALDOSE RÉDUCTASE ET LEURS UTILISATIONS
  申请人：UNIV COLUMBIA

  公开号：WO2012009553A1

  公开（公告）日：2012-01-19

  The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, infections of the skin, peripheral vascular disease, stroke, and the like.

  本发明涉及新型化合物及其制药组合物，以及促进皮肤健康老化、治疗皮肤疾病、治疗心血管疾病、治疗肾脏疾病、治疗血管生成异常如癌症、治疗组织损伤如非心脏组织损伤、治疗急性心肌梗死的演变和使用本发明中的化合物和组合物治疗各种其他疾病，如糖尿病并发症等。其他疾病可以包括但不限于动脉粥样硬化、冠状动脉疾病、糖尿病肾病、糖尿病神经病变、糖尿病视网膜病变、皮肤感染、周围血管疾病、中风等。
• Hiv integrase inhibitors
  申请人：Verschueren Wim Gaston

  公开号：US20060211724A1

  公开（公告）日：2006-09-21

  The present invention concerns the compounds having the formula (1), N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof wherein (a) or (b); A, together with the two carbons of the phenyl ring to which it is attached forms a monocyclic aryl or a monocyclic Het 2 ; R 1 is hydrogen, halo, nitro, cyano, sultam, sultim, C 3-7 cycloalkyl, C(═O)—R 5 , S(═O) y —R 6 , OR 7 , NR 8 R 9 , C(═NR 8 )—R 5 , optionally polysubstituted C 1-6 alkyl, optionally polysubstituted C 2-6 alkenyl or optionally polysubstituted C 2-6 alkynyl; R 2 is hydrogen, C 3-7 cycloalkyl, aryl, Het 1 , Het 2 , C(═O)—R 5 , S(═) y —R 6 OR 7 , NR 8 R 9 , C═NR 8 )—R 5 , or optionally polysubstituted C 1-6 alkyl, optionally polysubstituted C 2-6 alkenyl or optionally polysubstituted C 2-6 alkynyl. It further relates to their use as HIV integrase inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. It also concerns combinations thereof with other anti-retroviral agents, and to their use in assays as reference compounds or as reagents.

  本发明涉及具有式（1）的化合物，N-氧化物，盐，立体异构体，外消旋混合物，前药，酯和其代谢物，其中（a）或（b）; A与其附着的苯环的两个碳形成单环芳基或单环Het2; R1是氢，卤素，硝基，氰基，磺酰胺，磺酰亚胺，C3-7环烷基，C（═O）-R5，S（═O）y-R6，OR7，NR8R9，C（═NR8）-R5，可选地多取代的C1-6烷基，可选地多取代的C2-6烯基或可选地多取代的C2-6炔基; R2是氢，C3-7环烷基，芳基，Het1，Het2，C（═O）-R5，S（═）y-R6OR7，NR8R9，C═NR8）-R5，或可选地多取代的C1-6烷基，可选地多取代的C2-6烯基或可选地多取代的C2-6炔基。它进一步涉及它们作为HIV整合酶抑制剂的用途，它们的制备过程以及包含它们的制药组合物和诊断试剂盒。它还涉及它们与其他抗逆转录病毒药物的组合，以及它们作为参考化合物或试剂在测定中的使用。
• RESIN COMPOSITION AND SEMICONDUCTOR DEVICE BOARD
  申请人：Osaku Yumi

  公开号：US20140087136A1

  公开（公告）日：2014-03-27

  A resin composition which contains a binder resin (A), radiation-sensitive compound (B), silane-modified resin (C), and antioxidant (D), wherein a content of the silane-modified resin (C) is 0.1 to 150 parts by weight with respect to 100 parts by weight of the binder resin (A), a content of the antioxidant (D) is 0.1 to 10 parts by weight with respect to 100 parts by weight of the binder resin (A), and an amount of warping is 14 μm or less when using the resin composition to form a thickness 2 to 3 μm resin film and baking the formed resin film at 230° C. is provided.

  一种树脂组合物，包含粘合剂树脂（A），辐射敏感化合物（B），硅改性树脂（C）和抗氧化剂（D），其中硅改性树脂（C）的含量相对于100份粘合剂树脂（A）为0.1至150份重量，抗氧化剂（D）的含量相对于100份粘合剂树脂（A）为0.1至10份重量，并且使用该树脂组合物形成2至3μm厚度的树脂膜并在230°C下烘烤形成的树脂膜翘曲量为14μm或以下。
• ALDOSE REDUCTASE INHIBITORS AND USES THEREOF
  申请人：WASMUTH Andrew

  公开号：US20130225592A1

  公开（公告）日：2013-08-29

  The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, infections of the skin, peripheral vascular disease, stroke, and the like.

  本发明涉及新型化合物及其制药组合物，以及促进皮肤健康老化、治疗皮肤疾病、治疗心血管疾病、治疗肾脏疾病、治疗血管生成障碍（如癌症）、治疗组织损伤（如非心脏组织损伤）、治疗心肌梗死发展以及使用本发明的化合物和组合物治疗其他各种疾病（如糖尿病并发症）。其他疾病可以包括但不限于动脉粥样硬化、冠状动脉疾病、糖尿病肾病、糖尿病神经病、糖尿病视网膜病变、皮肤感染、外周血管疾病、中风等。
• Substituted pyridazines, processes for making them, their use as plant growth regulators, and plant growth regulating compositions containing them
  申请人：ROHM AND HAAS COMPANY

  公开号：EP0049971A1

  公开（公告）日：1982-04-21

  Novel substituted pyridazines are provided which exhibit plant growth regulating activity on gramineous plants such as cereals. The novel compounds are of Formula (I) wherein R' is (C1-C4) alkyl, phenyl or naphthyl each of the last two groups being optionally substituted with up to three of the same or different substituents selected from halogen, trihalomethyl, (C1-C4) alkoxy, (C1-C4) alkyl and cyano; R3 is hydrogen or a group as defined below for R5; R5 is a carboxy (-COOH) group or agronomically acceptable alkali metal salt thereof, an alkoxycarbonyl (-COOR) group or a substituted carbamoyl (-CONR'R") group, wherein R represents (C1-C4) alkyl, R' represents hydrogen or (C1-C4) alkyl and R" represents (C1-C4) alkyl; and R6 is a (C1-C4) alkyl group or an optionally substituted phenyl or naphthyl group as defined for R' above. Also provided are agronomically acceptable acid addition salts of compounds of Formula (I).

  本发明提供的新型取代哒嗪类化合物对禾本科植物（如谷物）具有植物生长调节活性。这些新型化合物如式 (I) 所示 其中，R'是(C1-C4)烷基、苯基或萘基，后两个基团中的每一个可任选被至多三个相同或不同的取代基取代，这些取代基可选自卤素、三卤甲基、(C1-C4)烷氧基、(C1-C4)烷基和氰基；R3 是氢或如下定义的 R5 基团；R5 是羧基 (-COOH) 或其农艺上可接受的碱金属盐、烷氧基羰基 (-COOR) 或取代的氨基甲酰基 (-CONR'R")，其中 R 代表 (C1-C4) 烷基，R'代表氢或 (C1-C4) 烷基，R "代表 (C1-C4) 烷基；以及 R6 是 (C1-C4) 烷基或任选取代的苯基或萘基，如上文对 R' 所定义。 还提供了农艺学上可接受的式 (I) 化合物的酸加成盐。